Myles Minter
Stock Analyst at William Blair
(1.97)
# 3,120
Out of 5,154 analysts
25
Total ratings
47.37%
Success rate
3.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Upgrades: Outperform | n/a | $11.18 | - | 3 | Feb 17, 2026 | |
| NMRA Neumora Therapeutics | Upgrades: Outperform | n/a | $3.02 | - | 2 | Feb 17, 2026 | |
| BHVN Biohaven | Downgrades: Market Perform | n/a | $9.92 | - | 1 | Nov 5, 2025 | |
| ALEC Alector | Downgrades: Market Perform | n/a | $2.00 | - | 2 | Oct 22, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $65.20 | - | 1 | Jul 2, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $1.23 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $4.20 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $717.79 | - | 2 | Nov 1, 2024 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $7.11 | +898.59% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $52.52 | - | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $456.69 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $310.71 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $5.22 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $320.66 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $74.04 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $128.13 | -9.47% | 1 | Feb 24, 2020 |
Korro Bio
Feb 17, 2026
Upgrades: Outperform
Price Target: n/a
Current: $11.18
Upside: -
Neumora Therapeutics
Feb 17, 2026
Upgrades: Outperform
Price Target: n/a
Current: $3.02
Upside: -
Biohaven
Nov 5, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $9.92
Upside: -
Alector
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $2.00
Upside: -
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $65.20
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $1.23
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $4.20
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $717.79
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $7.11
Upside: +898.59%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $52.52
Upside: -
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $456.69
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $310.71
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $5.22
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $320.66
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $74.04
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $128.13
Upside: -9.47%